Clinical Maestro® by Strategikon is an end-to-end elegant cloud-based platform to more efficiently budget, source and manage complex clinical programs. We believe that intuitive technology, complete transparency and effective communication between biopharmaceutical companies and providers will revolutionize the productivity of clinical research. Clinical Maestro™: New Ways to Solve Old Problems.
Location: United States, California, San Rafael
Employees: 11-50
Founded date: 2017
Investors 6
| Date | Name | Website |
| - | Life Scien... | lifescienc... |
| 26.10.2023 | Sofia Fund | sofiafund.... |
| - | Band of An... | bandangels... |
| - | HearstLab | hearstlab.... |
| - | SeedFolio | seedfolio.... |
| - | NuFund Ven... | nufund.com |
Mentions in press and media 7
| Date | Title | Description |
| 06.02.2024 | Strategikon Closes Series A1 Funding Round to Modernize Clinical Trials Business Operations Worldwide | Strategikon logo Led by Osage Venture Partners, Debiopharm, HearstLab, and Golden Seeds This milestone underscores the belief in Strategikon's vision to redefine strategic intelligence in the pharmaceutical landscape. The trust from our inv... |
| 12.07.2023 | Strategikon Unveils Clinical Maestro 4.1, Delivering Enhanced Functionality and Customer-Centric Product Development | This innovative solution offers significant advancements including automated SOWs, updated benchmarking and comprehensive vendor performance data We are dedicated to providing our customers advanced solutions to streamline their clinical tr... |
| 06.02.2023 | Strategikon and 4C Join Forces to Streamline Biopharmaceutical Clinical Operations | Strategikon Pharma 4C Life Sciences Strategic Partnership Will Accelerate Clinical Outsourcing for Biopharma of All Sizes Customers are streamlining the RFP process and reducing time spent in clinical outsourcing using our Clinical Maestro ... |
| 03.08.2021 | Strategikon Enhances Clinical Trial Planning and Outsourcing. Speeds Time-to-Market. | |
| 22.04.2021 | Strategikon Pharma Announces Close of Series A Financing | |
| 22.04.2021 | Strategikon Pharma : Announces Close of Series A Financing | SAN FRANCISCO, April 22, 2021 /PRNewswire/ -- Strategikon Pharma, a leader in digital business technology to accelerate planning, budgeting, and outsourcing for clinical trials, announced the closing of Series A financing. The round was led... |
| 13.10.2020 | Strategikon Launches Two New Business Operation Services To Provide Fast Relief For Intense Clinical Budget Season |